Texas Retina’s Ashkan Abbey, MD, recently collaborated with colleagues from the Department of Ophthalmology at University of Texas Southwestern Medical Center in Dallas, to publish a case report in Retinal Cases & Brief Reports, examining the use of an injectable intravitreal fluocinolone acetonide implant (YUTIQ) for chronic postoperative cystoid macular edema (CME) in the presence of silicone oil tamponade.
Cystoid macular edema is a disorder affecting the macula, which is the central part of the retina, resulting in cyst-like areas of fluid that cause retinal swelling (edema). The patient in this case report had multiple complicated vitreoretinal surgical procedures, including long-term silicone oil tamponade to help push and hold the retina in place. The eye had developed chronic CME, which responded to intravitreal steroid therapies, and Dr. Abbey placed the fluocinolone acetonide implant for long-term control. There have been no complications to date.
“We are always striving to improve care for our patients and to our knowledge, this case represents the first report in the literature describing the use of the 0.18-mg injectable fluocinolone implant in a silicone oil–filled eye,” shares Dr. Abbey. “It is a long-acting steroid that we believe may be beneficial in controlling chronic CME.”
Click here to access the case report.
Dr. Abbey serves as Texas Retina’s Director of Clinical Research for Dallas and cares for patients in our Dallas Main and Rockwall offices. You can learn more about him here.